AstraZeneca Plc (NASDAQ:AZN) is reportedly reconsidering its planned $578.4 million (450 million pounds) investment in a new vaccine-manufacturing site, a departure from CEO Pascal Soriot‘s ...
Despite expanding and adding hundreds of new jobs in states like Ohio in the past year, biomanufacturing CDMO National ...
AstraZeneca is backing up its considerable ... Chief executive Pascal Soriot said the plant will help AZ achieve its ambition to position ADCs as a replacement for traditional chemotherapies ...
CAMBRIDGE, England, November 12, 2024--(BUSINESS WIRE)--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and ...
With an increase in ageing populations, a rising burden of chronic disease, and the growing impact of the climate crisis on ...
FDA approves AstraZeneca’s Imfinzi for limited-stage small cell lung cancer, cutting the risk of death by 27% in the ADRIATIC ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...